Group 1: Market Overview - The Christmas week began with positive momentum from Big Tech, particularly driven by Nvidia's H200 chip, although gains were limited as traders sought safe-haven assets [1] - The U.S. economy showed stronger-than-expected growth at 4.3% for Q3, while durable goods orders fell by 2.2% in October [1] - The S&P 500 Index achieved a record close during the Christmas Eve session, and all three major indexes posted healthy weekly gains despite initial concerns about a "Santa Claus" rally [2] Group 2: Drug Industry Developments - Biohaven's treatment for major depressive disorder did not meet its primary objective in a phase 2 study, impacting its stock performance [3] - Novo Nordisk received FDA clearance for its GLP-1 pill, indicating a positive development for the company [3] - Vanda Pharmaceuticals is seeking approval for its antibody treatment for psoriasis, which could enhance its market position [3] Group 3: Technology Sector Highlights - Nvidia continues to attract bullish sentiment despite its stock's volatility, reflecting strong investor confidence [4] - Tesla reached new record highs, showcasing its ongoing growth and market interest [4] - Micron Technology extended its record-breaking performance, indicating robust demand in the semiconductor sector [4] Group 4: Upcoming Economic Reports - The upcoming week will feature key economic reports, including November's pending home sales and the minutes from the December FOMC meeting, which could influence market sentiment [5]